RESPARK - Brain Q for Chronic Stroke

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Sep 2026 → Mar 2027
See other at-risk trials from University of Florida

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Primary completion pushed from Sep 2026 to Mar 2027
    • Study completion pushed from Dec 2026 to Mar 2027
    • Eligibility criteria expanded, about 26 words
    • Site details revised
  2. Primary completion pushed from May 2026 to Sep 2026v5
  3. Primary completion date: Mar 2026 to May 2026v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 2025 to Aug 27, 2025
    • Site details revised
    v3
  5. Start date: Jul 2025 to Aug 2025v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Florida
327 trials monitored
See 23 trials at risk
Stroke
3,537 trials monitored
See 161 trials at risk
This trial tests a promising new intervention to promote post-stroke neural reorganization and functional recovery. The Q Therapeutic (BQ 3.0) is a wearable medical system that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery. This trial is a prospective, single-arm, open-label, single center clinical trial designed to evaluate the safety, feasibility, and efficacy of the Q Therapeutic (BQ 3.0) System in the rehabilitation of people with chronic stroke.
Trial Details
NCT Number NCT07095920
Lead Sponsor University of Florida
Collaborators: BrainQ Technologies Ltd., Brooks Rehabilitation
Conditions
(from sponsor)		 Stroke, Chronic Stroke Patients, Cerebrovascular Accident (CVA)
Related terms Motor Activity, Stroke
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov